New Science Ventures — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Vascular TherapiesMar 2022SEC filingmedium confidence
BiotechCresskill, US
Sriram Iyer(Executive Officer, Director)
BoardKiyoshi Takesue(Director)Robert Flanagan(Director)Allan Tessler(Director)Michael Bamberger(Director)
Board seatSomu Subramaniam· per SEC Form D · $25.2M raise · filed Mar 2022
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.